ABUS
Arbutus Biopharma Corp
4.90$
-0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Arbutus Biopharma Corp (ABUS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -6.0 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -22 | -17 | -19 | -15 | -21 | -10 | -13 | -16 | -5.8 | -4.7 | -8.1 | -6.0 | -25 | |
| 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 2.5 | 1.7 | 2.0 | 3.2 | 2.2 | 1.6 | 3.6 | 0.9 | 1.3 | 1.3 | 1.4 | 1.6 | 5.5 | |
| -3.4 | 1.5 | -2.9 | 2.8 | -2.5 | -0.2 | 5.3 | -18 | 1.2 | 1.8 | -178 | -2.2 | -177 | |
| 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 8.1 | 6.0 | 14 | |
| 10 | 22 | 12 | 9.8 | -12 | 13 | 11 | 16 | -10 | -1.4 | 2.2 | -1.7 | -11 | |
| 1.7 | 3.8 | 24 | 24 | 1.8 | 1.4 | 2.8 | 0.5 | 0.8 | 1.6 | 12 | 3.1 | 17 | |
| -9.7 | 8.8 | 17 | 20 | -31 | 4.5 | 0.7 | 0.3 | -15 | -4.4 | 5.7 | -4.5 | -18 | |
| -22 | -17 | -19 | -15 | -21 | -10 | -13 | -16 | -5.8 | -4.7 | -8.1 | -6.0 | -25 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.